INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 242 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6,644 | +405.2% | 97 | +410.5% | 0.00% | – |
| Q1 2024 | $1,315 | -3.4% | 19 | 0.0% | 0.00% | – |
| Q4 2023 | $1,361 | +37.5% | 19 | 0.0% | 0.00% | – |
| Q3 2023 | $990 | -17.8% | 19 | 0.0% | 0.00% | – |
| Q2 2023 | $1,204 | +17.0% | 19 | 0.0% | 0.00% | – |
| Q1 2023 | $1,029 | +21.5% | 19 | +18.8% | 0.00% | – |
| Q4 2022 | $847 | -15.3% | 16 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 16 | +23.1% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 13 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | – | 13 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 360,000 | $11,502,000 | 2.65% |
| Redmile Group, LLC | 610,171 | $19,495,000 | 1.60% |
| Pier Capital, LLC | 257,256 | $8,219,000 | 1.18% |
| WALL STREET ASSOCIATES | 358,857 | $11,465,000 | 1.08% |
| SENZAR ASSET MANAGEMENT, LLC | 161,300 | $5,154,000 | 0.88% |
| Rhenman & Partners Asset Management AB | 206,000 | $6,582,000 | 0.79% |
| EAM Investors, LLC | 152,389 | $4,869,000 | 0.57% |
| EDMOND DE ROTHSCHILD (SUISSE) S.A. | 50,000 | $1,598,000 | 0.51% |
| Visium Asset Management, LP | 1,051,479 | $33,595,000 | 0.48% |
| SPHERA FUNDS MANAGEMENT LTD. | 128,000 | $4,090,000 | 0.40% |